Psyence Biomedical Ltd (PBM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PBM | AMGN | VRTX | BMY | GILD |
| Company | Psyence Biomedical Ltd | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 0.6882 | 328.70 | 440.46 | 56.46 | 123.80 |
| High | 0.6900 | 333.03 | 445.77 | 56.56 | 125.12 |
| Low | 0.6147 | 326.90 | 437.46 | 55.10 | 122.10 |
| Latest | 0.6700 | 330.41 | 441.36 | 55.26 | 124.91 |
| Change | -0.0001 | +0.38 | +2.44 | -1.36 | +3.65 |
| % Change | -0.01% | +0.12% | +0.56% | -2.40% | +3.01% |
| Volume | 506,800 | 4,033,800 | 2,047,400 | 13,702,800 | 10,639,000 |
| 20-Day Average Volume | 2,126,035 | 2,749,175 | 1,381,860 | 14,318,740 | 6,405,805 |
| Previous Close | 0.6701 | 330.03 | 438.92 | 56.62 | 121.26 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8430 | 329.14 | 457.40 | 54.90 | 122.91 |
| 20-Day Raw Stochastic | 5.96% | 49.11% | 9.19% | 64.26% | 76.26% |
| 20-Day Relative Strength | 28.83 | 52.74 | 46.77 | 59.07 | 53.81 |
| Weighted Alpha | -86.82 | +22.07 | +4.19 | +6.63 | +32.21 |
| Today's Opinion | 100% Sell | 64% Buy | 40% Buy | 100% Buy | 72% Buy |
| Previous Opinion | 100% Sell | 80% Buy | 40% Buy | 100% Buy | 40% Buy |
| Last Month's Opinion | 100% Sell | 72% Buy | 56% Buy | 72% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.25% since 01/09/26 | +1.32% since 01/09/26 | -4.85% since 01/09/26 | -1.07% since 01/09/26 | +3.15% since 01/09/26 |
| Low | 0.6147 on 01/16/26 | 319.79 on 01/13/26 | 436.69 on 01/15/26 | 55.10 on 01/16/26 | 119.63 on 01/12/26 |
| High | 0.8300 on 01/12/26 | 333.03 on 01/16/26 | 464.59 on 01/12/26 | 57.04 on 01/14/26 | 125.12 on 01/16/26 |
| 1-Month | |||||
| %Chg | -56.21% since 12/16/25 | +1.12% since 12/16/25 | -2.99% since 12/16/25 | +1.90% since 12/16/25 | +5.16% since 12/16/25 |
| Low | 0.6147 on 01/16/26 | 318.21 on 01/05/26 | 436.69 on 01/15/26 | 52.06 on 01/05/26 | 116.88 on 01/05/26 |
| High | 1.5424 on 12/18/25 | 343.05 on 01/07/26 | 487.52 on 01/07/26 | 57.04 on 01/14/26 | 127.41 on 12/23/25 |
| 3-Month | |||||
| %Chg | -80.58% since 10/16/25 | +11.70% since 10/16/25 | +8.01% since 10/16/25 | +27.36% since 10/16/25 | +5.99% since 10/16/25 |
| Low | 0.6147 on 01/16/26 | 288.00 on 10/31/25 | 403.16 on 11/04/25 | 42.52 on 10/29/25 | 114.02 on 10/31/25 |
| High | 3.5600 on 10/17/25 | 346.38 on 12/03/25 | 487.52 on 01/07/26 | 57.04 on 01/14/26 | 128.70 on 11/20/25 |
| 6-Month | |||||
| %Chg | -87.14% since 07/16/25 | +10.50% since 07/16/25 | -6.00% since 07/16/25 | +17.15% since 07/16/25 | +13.71% since 07/16/25 |
| Low | 0.6147 on 01/16/26 | 269.77 on 09/26/25 | 362.50 on 08/11/25 | 42.52 on 10/29/25 | 107.75 on 07/21/25 |
| High | 11.9900 on 07/25/25 | 346.38 on 12/03/25 | 487.52 on 01/07/26 | 57.04 on 01/14/26 | 128.70 on 11/20/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,251 | 177,919,520 | 111,981,408 | 112,495,712 | 154,973,344 |
| Shares Outstanding, K | 1,867 | 538,481 | 253,719 | 2,035,753 | 1,240,680 |
| Annual Sales | 0 | 33,424,000,000 | 11,020,100,000 | 48,300,000,000 | 28,754,000,000 |
| Annual Net Income | 1,010,000 | 4,090,000,000 | -535,600,000 | -8,948,000,000 | 480,000,000 |
| Last Quarter Sales | 0 | 9,557,000,000 | 3,076,400,000 | 12,222,000,000 | 7,769,000,000 |
| Last Quarter Net Income | -750,000 | 3,216,000,000 | 1,082,900,000 | 2,201,000,000 | 3,052,000,000 |
| 60-Month Beta | 0.32 | 0.45 | 0.31 | 0.29 | 0.33 |
| Per-Share Information | |||||
| Most Recent Earnings | 4.05 on 01/23/25 | 5.64 on 11/04/25 | 4.80 on 11/03/25 | 1.63 on 10/30/25 | 2.47 on 10/30/25 |
| Latest Earnings Date | 01/22/26 | 02/03/26 | 02/09/26 | 02/05/26 | 02/10/26 |
| Most Recent Dividend | N/A | 2.380 on 11/21/25 | N/A | 0.630 on 01/02/26 | 0.790 on 12/15/25 |
| Next Ex-Dividends Date | N/A | 02/13/26 | N/A | 01/02/26 | 12/15/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.09 | 28.67 | 8.63 | 14.81 |